| 000 | 01863 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517132839.0 | ||
| 264 | 0 | _c20170621 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1477-7819 | ||
| 024 | 7 |
_a10.1186/s12957-016-1066-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQi, Nienie | |
| 245 | 0 | 0 |
_aCytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience. _h[electronic resource] |
| 260 |
_bWorld journal of surgical oncology _cJan 2017 |
||
| 300 |
_a4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xmortality |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytoreduction Surgical Procedures _xmortality |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xmortality |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmortality |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNephrectomy _xmortality |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThrombectomy _xmortality |
| 650 | 0 | 4 |
_aThrombosis _xmortality |
| 650 | 0 | 4 |
_aVena Cava, Inferior _xpathology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWu, Pengjie | |
| 700 | 1 | _aChen, Jinchao | |
| 700 | 1 | _aLi, Teng | |
| 700 | 1 | _aNing, Xianghui | |
| 700 | 1 | _aWang, Jin | |
| 700 | 1 | _aGong, Kan | |
| 773 | 0 |
_tWorld journal of surgical oncology _gvol. 15 _gno. 1 _gp. 4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12957-016-1066-3 _zAvailable from publisher's website |
| 999 |
_c26756340 _d26756340 |
||